35 articles
Alan Horwich
Alan Horwich (born 1948) is a British clinical oncologist, Professor of Radiotherapy at the Institute of Cancer Research and Royal Marsden Hospital from 1986 to 2013.
Amato J. Giaccia
Amato J. Giaccia is a radiation and cancer biologist, emeritus professor at Stanford School of Medicine and Director of the Oxford Institute of Radiation Oncology.
Andrea K. Ng
Andrea K. Ng, also known as Andrea Ng, is an American radiation oncologist at Dana-Farber and Harvard known for research on late effects of Hodgkin lymphoma treatment.
Anthony V. D’Amico
Anthony Victor D'Amico is an American radiation oncologist, chief of Genitourinary Radiation Oncology at Dana-Farber and Harvard professor, known for his 1998 prostate cancer risk classification.
Chris Parker
Chris Parker is a British clinical oncologist specializing in prostate cancer radiotherapy, Professor of Prostate Oncology at The Institute of Cancer Research, who led the radium-223 ALSYMPCA trial.
Claudius Regaud
Claudius Regaud (1870–1940) was a French physician and biologist who founded French radiotherapy, co-founded the Fondation Curie with Marie Curie, and established the dose fractionation principle underlying modern radiation oncology.
Cornelius A. Tobias
Cornelius A. Tobias (1918–2000) was a Hungarian-born American biophysicist at UC Berkeley who pioneered heavy-ion cancer therapy, pituitary radiosurgery, and space radiation research, winning the 1963 E.O. Lawrence Award.
Daphne Haas-Kogan
Daphne Haas-Kogan is an American radiation oncologist who treats brain tumors and pediatric cancers and chairs radiation oncology at Brigham and Women's Hospital and Massachusetts General Hospital.
David Kirsch
David G. Kirsch is an American radiation oncologist and cancer biologist, a University of Toronto professor known for sarcoma mouse models and the SU2C-SARC032 immunotherapy trial.
David P. Dearnaley
David P. Dearnaley is a British radiation oncologist and Emeritus Professor of Uro-Oncology at the Institute of Cancer Research, known for prostate cancer radiotherapy trials.
Dennis E. Hallahan
Dennis E. Hallahan is an American radiation oncologist and cancer researcher, head of Radiation Oncology at Washington University in St. Louis since 2009, known for radiation-inducible gene therapy.
Felix Y. Feng
Felix Y. Feng (1975–2024) was an American radiation oncologist and prostate cancer researcher who was a professor at UCSF and developed the first clinical-grade biomarker panels predicting hormone- and radiation-therapy response.
Harold E. Johns
Harold E. Johns (Harold Elford Johns) was a Canadian medical physicist who led the design of one of the first cobalt-60 cancer therapy units, the "cobalt bomb", in 1951.
Henri Coutard
Henri Coutard (1876–1950) was a French radiation therapist at the Curie Institute in Paris who pioneered fractionated radiotherapy, delivering small daily radiation doses over several weeks.
Henry S. Kaplan
Henry S. Kaplan (1918–1984) was an American radiation oncologist and cancer biologist at Stanford who developed the first medical linear accelerator in the Western hemisphere and helped make Hodgkin's disease curable.
Howard M. Sandler
Howard M. Sandler is an American radiation oncologist specializing in prostate cancer who became Chair of Radiation Medicine at Oregon Health & Science University in 2026.
Jean Bourhis
Jean Bourhis is a French radiation oncologist, professor and chair of radiation oncology at Lausanne University Hospital since 2012, known for the MACH-NC and MARCH meta-analyses.
Jens Overgaard
Jens Overgaard is a Danish physician-scientist and professor of experimental clinical oncology at Aarhus University Hospital, known for the DAHANCA fractionation trials in head-and-neck cancer.
Larry E. Kun
Larry E. Kun (1946–2018) was an American pediatric radiation oncologist who built St. Jude's brain tumor program and led trials delaying radiation for young children.
Lori J Pierce
Lori J Pierce is an American radiation oncologist at the University of Michigan who studies breast cancer radiotherapy and served as president of ASCO in 2020-2021.
M. Frederick Hawthorne
M. Frederick Hawthorne (1928–2021) was an American inorganic chemist nicknamed "Mr. Boron" who established boron cluster chemistry, pursued boron neutron capture therapy for cancer, and won the Priestley Medal and National Medal of Science.
Minesh P. Mehta
Minesh P. Mehta is a radiation oncologist and physician-scientist, deputy director and chief of radiation oncology at Baptist Health Miami Cancer Institute, and a brain tumor clinical trials leader.
Peter M. Glazer
Peter M. Glazer is an American radiation oncologist and physician-scientist who chairs the Department of Therapeutic Radiology at Yale, known for research on DNA repair, tumor hypoxia, and gene editing.
Philip Rubin
Philip Rubin (1927–2014) was an American radiation oncologist who built the University of Rochester's radiation oncology department and became an international authority on late radiation effects on normal tissue.
Radiation Oncologists
Radiation oncologists, also called radiotherapists or therapeutic radiologists, are physicians trained to treat cancer with radiation. They lead a team of physicists and dosimetrists, practice fractionation developed in the 1920s, and number over 5,300 in the US.
Ralph R. Weichselbaum
Ralph R. Weichselbaum is an American physician-scientist in radiation oncology who chairs radiation oncology at the University of Chicago and defined the oligometastasis stage of cancer spread.
Ruijiang Li
Ruijiang Li is a Stanford Associate Professor of Radiation Oncology who develops AI foundation models for precision oncology, including MUSK, published in Nature in 2025.
Samuel Hellman
Samuel Hellman is an American radiation oncologist, A. N. Pritzker Distinguished Service Professor Emeritus at the University of Chicago, who with Ralph Weichselbaum originated the oligometastases concept.
Shekinah Elmore
Shekinah Elmore was an American radiation oncologist and global oncology researcher at UNC Chapel Hill who, diagnosed with two cancers at 27, wrote publicly about living with Li-Fraumeni syndrome.
Suresh Senan
Suresh Senan is a Dutch-based radiation oncologist and professor at Amsterdam University Medical Centers, known for the SABR-COMET trial and lung cancer radiotherapy research, and recipient of the 2016 Heine H. Hansen Award.